PGC-1α is highly expressed in tissues with high energy demands, and it is clearly associated with the pathogenesis of metabolic syndrome and its principal complications including obesity, type 2 diabetes mellitus, cardiovascular disease, and hepatic steatosis. This evidence concerns the gene PPARGC1A and obesity due to melanocortin 4 receptor deficiency.